Skip to Main Content

Author Details

Venky Soundararajan
inc. 2424 Erwin Road
2009
45
20
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36604461Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants.Sci Rep2023
37403432Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.Am J Hematol2023
36963910Paediatric safety assessment of BNT162b2 vaccination in a multistate hospital-based electronic health record system in the USA: a retrospective analysis.Lancet Digit Health2023
34927113Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.Med2022
35420661Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.JAMA Netw Open2022
35860600SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes.PNAS Nexus2022
36713312Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection.PNAS Nexus2022
36713311Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19.PNAS Nexus2022
36712796Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern.PNAS Nexus2022
36523407Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions.medRxiv2022
35899067Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure.PNAS Nexus2022
35156767High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein.Mol Syst Biol2022
35314694Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest.Cell Death Discov2022
34189429Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance.iScience2021
33718845Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients.EClinicalMedicine2021
33666246Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry.J Med Virol2021
33637783Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations.Sci Rep2021
33778434Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.EClinicalMedicine2021
33723251Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.Cell Death Discov2021
34401884Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence.medRxiv2021
34726743Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.JAMA Netw Open2021
34579210Counties with Lower Insurance Coverage and Housing Problems Are Associated with Both Slower Vaccine Rollout and Higher COVID-19 Incidence.Vaccines (Basel)2021
34627592Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System.J Stroke Cerebrovasc Dis2021
34223401FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.Med2021
34179842Building a best-in-class automated de-identification tool for electronic health records through ensemble learning.Patterns (N Y)2021
34230920Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.Med2021
32452762SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.Elife2020
33024578Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.Cell Death Discov2020
33298894Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity.Cell Death Discov2020
32577666Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity.medRxiv2020
32804081Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).Elife2020
32633720Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis.Elife2020
32463365Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors.Elife2020
28991237Corrigendum: Engineering and optimising deaminase fusions for genome editing.Nat Commun2017
27804970Engineering and optimising deaminase fusions for genome editing.Nat Commun2016
25465236Global connectivity of hub residues in Oncoprotein structures encodes genetic factors dictating personalized drug response to targeted Cancer therapy.Sci Rep2014
20699282The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation.Innate Immun2011
22355715Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation.Sci Rep2011
20186337Atomic interaction networks in the core of protein domains and their native folds.PLoS One2010
21590893Multifunctional nanoscale platforms for targeting of the cancer cell immortality spectrum.Macromol Rapid Commun2010
21133125A voxel-based Monte Carlo model of drug release from bulk eroding nanoparticles.J Nanosci Nanotechnol2010
18849565Recombinant expression, purification, and biochemical characterization of chondroitinase ABC II from Proteus vulgaris.J Biol Chem2009
19513050Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus.Nat Biotechnol2009
19726671Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.J Biol Chem2009
19726673Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.J Biol Chem2009
  • 1 - 45 of 45

Recommended Authors

Adam J Moore
Yale School of Public Health
Career Start Year 2019
Number of shared co-authors 0
Aysun Tekin
Mayo Clinic
Career Start Year 2018
Number of shared co-authors 6
Patrick W Johnson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2018
Number of shared co-authors 2
Seth Russell
University of Colorado School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Juan Soto
Icahn School of Medicine at Mount Sinai
Career Start Year 2016
Number of shared co-authors 1
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 0
Adrienne Baughman
Vanderbilt University Medical Center
Career Start Year 2015
Number of shared co-authors 0
Guillaume Butler-Laporte
McGill University
Career Start Year 2014
Number of shared co-authors 0
Nicholas E Ingraham
University of Minnesota Medical Center
Career Start Year 2012
Number of shared co-authors 0
Victor B Talisa
University of Pittsburgh School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Mark W Tenforde
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 1
Meagan E Deming
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Michael C Maher
Vir Biotechnology Inc.
Career Start Year 2011
Number of shared co-authors 1
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Benjamin T Bradley
University of Washington
Career Start Year 2009
Number of shared co-authors 0
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 0
Wade Schulz (CM4AI)
Yale University
Career Start Year 2008
Number of shared co-authors 1
Alexander W Charney
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 0
Alexander L Greninger
University of Washington Medical Center
Career Start Year 2008
Number of shared co-authors 1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Kenneth J Wilkins
National Institute of Diabetes and Digestive and Kidney Disease
Career Start Year 2007
Number of shared co-authors 0
John Kenneth Baillie
Roslin Institute, University of Edinburgh
Career Start Year 2005
Number of shared co-authors 1
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Wan-Mui Chan
School of Clinical Medicine, The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 1
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Pardis C Sabeti
Harvard University
Career Start Year 1997
Number of shared co-authors 2
Adam S Lauring
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 0
Charles Y Chiu
University of California-San Francisco
Career Start Year 1991
Number of shared co-authors 0
Jennifer J Hadlock
Institute for Systems Biology
Career Start Year 1991
Number of shared co-authors 0

Collaborators

John C O'Horo
Mayo Foundation for Medical Education and Research
Co-authored papers 22
John Halamka
Mayo Clinic, MN Mayo Clinic Platform
Co-authored papers 16
Karthik Murugadoss
Indian Institute of Technology Madras
Co-authored papers 6
William A Faubion
Mayo Clinic
Co-authored papers 4
Feng Zhang
Massachusetts Institute of Technology, USA Broad Institute
Co-authored papers 2
John Aach
Harvard Medical School
Co-authored papers 2
Yinan Kan
eGenesis Inc.
Co-authored papers 2
Marc G??ell
Universitat Pompeu Fabra
Co-authored papers 2
Brian W Pickering
Mayo Clinic
Co-authored papers 2
Luhan Yang
College of Resources and Environment, Southwest University
Co-authored papers 2
Daniel B Goodman
University of California San Francisco
Co-authored papers 2
Adrian W Briggs
Harvard University
Co-authored papers 2
Emal Lesha
University of Tennessee Health Science Center
Co-authored papers 2
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers 2
Wei Leong Chew
Genome Institute of Singapore
Co-authored papers 2
David B T Cox
Broad Institute of MIT and Harvard
Co-authored papers 2
George M Church
Harvard Medical School
Co-authored papers 2
Rahul Kashyap
Mayo Clinic
Co-authored papers 2
Philippe R Bauer
Mayo Clinic
Co-authored papers 1
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers 1
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 1
Vineet Agarwal
Co-authored papers 1
Kristopher A Standish
Janssen pharmaceutical companies of Johnson & Johnson (J&J)
Co-authored papers 1
Bradley A Malin
Vanderbilt University
Co-authored papers 1
Aron Marchler-Bauer
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 1
Vikas Bansal
Mayo Clinic
Co-authored papers 1
Jeff R Anderson
Mayo Clinic
Co-authored papers 1
Dina Gomaa
University of Cincinnati
Co-authored papers 1
Sairam Bade
Co-authored papers 1
Toomas Haller
Co-authored papers 1
Release 1.2